Found 371 matching trials
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
PHASE1The primary purpose of this study is to determine the safety and efficacy o...
Location
The Affiliated People's Hospital of Ningbo University
Neurocognitive Trajectories After BCMA CAR-T
N/AThe purpose of this research study is to evaluate cognitive changes over ti...
Location
Atrium Health Levine Cancer
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia
PHASE2This is an open-label, single-arm, Phase 2 study to evaluate the efficacy a...
Location
The First Hospital of Jilin University
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
PHASE2This phase II trial tests how well giving dasatinib and quercetin with cycl...
Location
Mayo Clinic in Rochester
A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma
PHASE1This study is a single-center, open Phase I study, to observe the effective...
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
PHASE1CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated...
Location
Children's Hospital, Zhejiang University School of Medicine
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma
PHASE1This phase I trial studies the side effects and best dose of BCMA CART cell...
Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma
NAThe clinical trial was designed as a single-arm, open-label clinical study,...
Location
The Second Affiliated Hospital of Soochow University
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases
EARLY_PHASE1This is a single-arm, open-label, investigator-initiated trial (IIT) design...
Location
Union Hospital, Tongji Medical College, Huazhong University of Science & Technology
Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia
EARLY_PHASE1Relapsed or refractory acute leukemia (R/R AL) is a life-threatening blood ...
Location
Department of Hematology, Zhujiang Hospital, Southern Medical University